Synthesis and properties of 7-((6-aryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl)methyl)theophyllines
The creation of new biologically active compounds is a promising area of modern medicinal chemistry. Heterocyclic systems play an important role in this process.Among them, it is necessary to note 1,2,4-triazole and xanthine, the presence of which in the structure of known medicines determines their...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
The State Expert Center of the Ministry of Health of Ukraine,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_4bd8308aeadc40ad85b668b99e2553f7 | ||
042 | |a dc | ||
100 | 1 | 0 | |a K. D. Bakumovska |e author |
700 | 1 | 0 | |a A. S. Hotsulia |e author |
245 | 0 | 0 | |a Synthesis and properties of 7-((6-aryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl)methyl)theophyllines |
260 | |b The State Expert Center of the Ministry of Health of Ukraine, |c 2023-02-01T00:00:00Z. | ||
500 | |a 10.32352/0367-3057.1.23.06 | ||
500 | |a 0367-3057 | ||
500 | |a 2617-9628 | ||
520 | |a The creation of new biologically active compounds is a promising area of modern medicinal chemistry. Heterocyclic systems play an important role in this process.Among them, it is necessary to note 1,2,4-triazole and xanthine, the presence of which in the structure of known medicines determines their pharmacological activity. The combination of these heterocycles within a single molecule can lead to the enhancement of the existing biological effect or the emergence of new useful properties. The aim of the work has been to synthesize new theophylline-containing 4-amino-1,2,4-triazole-3-thiol derivatives, study their physicochemical properties and predictive study of their biological potential. The research objects have been the 7-((6-aryl-[1,2,4]triazolo[3,4-b][1,3,4]-thiadiazol-3-yl)methyl)theophylline, which were obtained by condensation of the starting 7-((4-amino-5-mercapto-1,2,4-triazol-3-yl)methyl)theophylline with aromatic carboxylic acids (benzoic,2-methoxybenzoic, 3-methoxybenzoic, 2-bromo-5-methoxybenzoic,2-bromo-4-fluorobenzoic, 2-chloro-4-nitrobenzoic, 2-bromo-5-nitrobenzoic) in phosphorus oxychloride medium under heating. The structure of the intermediate 7-((4-amino-5-mercapto-1,2,4-triazol-3-yl)methyl)theophylline was formed by a multistep chemical transformation of 1,3-dimethylxanthine. The structure of the synthesized compounds has been confirmed by elemental analysis, 1H NMR and IR spectroscopy, their individuality has been established by chromatography-mass spectrometry. The feasibility of further biological research has been preliminarily assessed by an in silico method, in particular, molecular docking. Cyclooxygenase-2, lanosterol 14α-demethylase and anaplastic lymphoma kinase have been used as model enzymes. The most likely activity, which is quite probable in a number of synthesized compounds, is antifungal. In this context, 7-((6-(2-bromo-5-methoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl)methyl)theophylline looks particularly promising, as it exceeds ketoconazole in terms of the energy of intermolecular interactions with lanosterol 14α-demethylase. | ||
546 | |a UK | ||
690 | |a 1 | ||
690 | |a 2 | ||
690 | |a 4-triazole | ||
690 | |a theophylline | ||
690 | |a synthesis | ||
690 | |a properties | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Фармацевтичний журнал, Vol 1, Pp 58-65 (2023) | |
787 | 0 | |n https://pharmj.org.ua/index.php/journal/article/view/1339/1251 | |
787 | 0 | |n https://doaj.org/toc/0367-3057 | |
787 | 0 | |n https://doaj.org/toc/2617-9628 | |
856 | 4 | 1 | |u https://doaj.org/article/4bd8308aeadc40ad85b668b99e2553f7 |z Connect to this object online. |